This ground-breaking three-day professional development course provides managers and strategic planners with the intellectual and analytical tools to enable predictive assessment of drug legalisation on sector-specific investments and interests in a diversity of country contexts. The aim of the course is to provide a diversity of stake-holders with the confidence and accuracy to identify and determine the impact of drug legalisation on their activities.
Changes in national and regional level drug policy require public and corporate planners to anticipate an operating environment in which a range of narcotic drugs are legalised. Lessons learned from Uruguay, Colorado and Washington point to the importance of the financial, security, health and education sectors preparing for major shifts in legal and regulatory frameworks. Legalisation redefines the traditional risks associated with working in drug consumption, production and trafficking contexts, with implications for budgets, operating procedures and strategic assumptions. At the same time it creates new and unanticipated challenges, such as shifts in patterns of organised crime and conflict, and new public health issues that need to be identified and mitigated.
The course is intended for a diverse range of stakeholders whose work and interests are either directly or indirectly impacted by drug policy and/or operations in drug trade contexts (consumption, production and trafficking environments). This includes public officials and private consultants engaged in development, security and public health related work; corporations engaged in – for example – extractive, financial, security and infrastructure-related activities and advocacy groups.
Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.